ArticleACS catalysis2025
Accessing Arenes via the Hydrodeoxygenation of Phenolic Derivatives Enabled by Hydrazine.
Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Comprehensive Review of Catalytic Hydrodeoxygenation of Lignin-Derived Phenolics to Aromatics.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrodeoxygenation (HDO) is an effective method for converting lignin and its derived phenolic compounds to value-added aromatic chemicals and fuels. Efforts to exploit molecular hydrogen have been made to remove the hydroxyl group in lignin-derived phenolic compounds to make them appealing for the chemical industry. However, these processes rely on high pressure and expensive catalysts, presenting challenges in terms of safety, hydrogen storage, and cost-effectiveness. This highlights the demand for alternatives under more accessible reaction conditions. Herein, we present a methodology for the HDO of phenols and naphthols using Pd/C as a commercial heterogeneous catalyst employing hydrazine as a dual reagent for reducing and hydrazone formation. This paper presents an applicable substrate scope for the HDO of different naphthols and phenols including pharmaceutically relevant molecules such as paracetamol. Additionally, highly challenging steroid derivatives, such as β-estradiol, have been hydrodeoxygenated.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.